Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

astrazeneca limited - prilocaine hydrochloride 1%; prilocaine hydrochloride 10 mg/ml - solution for injection - 1 % - active: prilocaine hydrochloride 1% excipient: sodium chloride sodium hydroxide water for injection active: prilocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 5-7) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 5-7) water for injection

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - prilocaine hydrochloride 2%; prilocaine hydrochloride 20 mg/ml - solution for injection - 2 % - active: prilocaine hydrochloride 2% excipient: sodium chloride sodium hydroxide water for injection active: prilocaine hydrochloride 20 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 5-7) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 5-7) water for injection

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - prilocaine hydrochloride - solution for injection - 10mg/1ml

Australia - englanti - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of inflitration and nerve block techniques.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 17 july 2003 : lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.54 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

astra pharmaceuticals ltd - prilocaine hydrochloride - solution for injection - 0.5 per cent

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

dentsply limited - prilocaine hydrochloride felypressin - solution for injection - %v/v

Australia - englanti - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.54 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - indications as at 23 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block tecniques.